Azole Antifungal [EPC]

Azole Antifungal [EPC] was reported 157204 times

Drugs of the Azole Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL FLATULENCE 219 0.7228
1 PSEUDOALDOSTERONISM 119 0.6010
2 PERIOSTITIS 239 0.5532
3 FUSARIUM INFECTION 277 0.3957
4 CEREBRAL ASPERGILLOSIS 231 0.3756
5 PULMONARY VASCULITIS 188 0.3494
6 SCEDOSPORIUM INFECTION 245 0.3470
7 DISSEMINATED MUCORMYCOSIS 134 0.3401
8 TOTAL LUNG CAPACITY ABNORMAL 121 0.3111
9 SYSTEMIC MYCOSIS 346 0.2962
10 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 267 0.2880
11 PULMONARY MUCORMYCOSIS 146 0.2765
12 MUCORMYCOSIS 715 0.2749
13 ZYGOMYCOSIS 125 0.2671
14 DISSEMINATED ASPERGILLOSIS 119 0.2521
15 ASPERGILLOSIS 308 0.2357
16 ASPERGILLUS INFECTION 1413 0.2151
17 BRONCHOPULMONARY ASPERGILLOSIS 1624 0.2093
18 MITE ALLERGY 135 0.2061
19 SPIROMETRY ABNORMAL 117 0.1957
20 FUNGAEMIA 299 0.1898
21 SINUSITIS FUNGAL 151 0.1883
22 MENINGITIS CRYPTOCOCCAL 321 0.1834
23 VULVOVAGINAL SWELLING 333 0.1822
24 FEMALE GENITAL TRACT FISTULA 298 0.1744
25 MYCOTIC ALLERGY 144 0.1684
26 PNEUMONIA FUNGAL 643 0.1628
27 CRYPTOCOCCOSIS 262 0.1606
28 ACUTE MYELOID LEUKAEMIA RECURRENT 345 0.1605
29 SYSTEMIC CANDIDA 383 0.1524
30 COCCIDIOIDOMYCOSIS 167 0.1400
31 ACTINIC KERATOSIS 353 0.1359
32 CEREBRAL TOXOPLASMOSIS 126 0.1349
33 NEURITIS 208 0.1346
34 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 283 0.1329
35 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 183 0.1295
36 ENTEROCOCCAL BACTERAEMIA 137 0.1292
37 GRAFT VERSUS HOST DISEASE 920 0.1278
38 TEMPERATURE REGULATION DISORDER 285 0.1278
39 DUST ALLERGY 125 0.1274
40 SCHIZOAFFECTIVE DISORDER 224 0.1255
41 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 343 0.1240
42 GRAFT VERSUS HOST DISEASE IN SKIN 271 0.1229
43 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 399 0.1207
44 IMMUNE RECONSTITUTION SYNDROME 150 0.1162
45 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 123 0.1158
46 STENOTROPHOMONAS INFECTION 152 0.1120
47 ACINETOBACTER INFECTION 122 0.1114
48 VULVOVAGINAL BURNING SENSATION 648 0.1061
49 RESPIRATORY SYMPTOM 293 0.1029
50 CHRONIC SINUSITIS 385 0.1025
51 ENTEROCOCCAL INFECTION 495 0.1023
52 RADICULOPATHY 260 0.0986
53 LABELLED DRUG-DRUG INTERACTION ISSUE 140 0.0967
54 CYTOMEGALOVIRUS TEST POSITIVE 168 0.0942
55 HYPERPARATHYROIDISM SECONDARY 236 0.0941
56 ACUTE GRAFT VERSUS HOST DISEASE 430 0.0938
57 PROCTITIS 263 0.0938
58 LUNG OPACITY 245 0.0929
59 HISTOPLASMOSIS 163 0.0920
60 APLASTIC ANAEMIA 480 0.0918
61 CYTOMEGALOVIRUS INFECTION REACTIVATION 400 0.0905
62 BRAIN ABSCESS 229 0.0904
63 NEPHROGENIC ANAEMIA 412 0.0889
64 CYTOMEGALOVIRUS VIRAEMIA 394 0.0885
65 CONJUNCTIVITIS ALLERGIC 131 0.0884
66 CHRONIC GRAFT VERSUS HOST DISEASE 318 0.0880
67 VULVOVAGINAL CANDIDIASIS 119 0.0880
68 CANDIDA INFECTION 1423 0.0842
69 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 171 0.0838
70 DRUG LEVEL INCREASED 1387 0.0837
71 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 417 0.0836
72 CANDIDIASIS 333 0.0829
73 TOTAL LUNG CAPACITY DECREASED 132 0.0826
74 LEUKAEMIA RECURRENT 137 0.0810
75 SEBORRHOEIC DERMATITIS 130 0.0786
76 DRUG LEVEL BELOW THERAPEUTIC 434 0.0786
77 ORAL CANDIDIASIS 1032 0.0783
78 VENOOCCLUSIVE LIVER DISEASE 386 0.0781
79 PSEUDOMONAS INFECTION 653 0.0761
80 DISORGANISED SPEECH 139 0.0753
81 FEBRILE NEUTROPENIA 4978 0.0750
82 BACTERIAL SEPSIS 244 0.0748
83 HISTOPLASMOSIS DISSEMINATED 118 0.0743
84 NOCARDIOSIS 189 0.0738
85 PSEUDOMONAL SEPSIS 129 0.0736
86 KLEBSIELLA INFECTION 365 0.0721
87 MACULAR DEGENERATION 860 0.0719
88 CYSTITIS HAEMORRHAGIC 290 0.0719
89 ACUTE MYELOID LEUKAEMIA 1111 0.0712
90 FOETAL DEATH 368 0.0709
91 BK VIRUS INFECTION 239 0.0708
92 PULMONARY ALVEOLAR HAEMORRHAGE 394 0.0702
93 PATHOGEN RESISTANCE 635 0.0696
94 OESOPHAGEAL CANDIDIASIS 274 0.0687
95 ENTEROBACTER INFECTION 115 0.0684
96 FUNGAL SKIN INFECTION 276 0.0683
97 APLASIA 133 0.0679
98 VENOOCCLUSIVE DISEASE 170 0.0678
99 FORCED EXPIRATORY VOLUME DECREASED 191 0.0673
100 VULVOVAGINAL PAIN 321 0.0666
101 VULVOVAGINAL PRURITUS 335 0.0661
102 PLEURITIC PAIN 181 0.0655
103 ADENOVIRUS INFECTION 190 0.0654
104 FUNGAL INFECTION 2182 0.0654
105 PNEUMONIA KLEBSIELLA 120 0.0652
106 SQUAMOUS CELL CARCINOMA OF SKIN 394 0.0652
107 NEUTROPENIC COLITIS 134 0.0647
108 STEM CELL TRANSPLANT 160 0.0640
109 PNEUMONIA CYTOMEGALOVIRAL 124 0.0638
110 STAPHYLOCOCCAL BACTERAEMIA 275 0.0632
111 REBOUND ACID HYPERSECRETION 191 0.0631
112 ESCHERICHIA BACTERAEMIA 148 0.0629
113 TORSADE DE POINTES 487 0.0620
114 CYTOMEGALOVIRUS INFECTION 1016 0.0611
115 CYTOMEGALOVIRUS CHORIORETINITIS 119 0.0610
116 STAPHYLOCOCCAL SEPSIS 300 0.0607
117 ACUTE LYMPHOCYTIC LEUKAEMIA 171 0.0603
118 NORMOCHROMIC NORMOCYTIC ANAEMIA 180 0.0599
119 NEUTROPENIC SEPSIS 425 0.0594
120 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1636 0.0577
121 NEUROLOGICAL SYMPTOM 329 0.0575
122 MYCOBACTERIUM AVIUM COMPLEX INFECTION 152 0.0566
123 FOOD ALLERGY 437 0.0566
124 VULVOVAGINAL DISCOMFORT 243 0.0549
125 HYPERPHOSPHATAEMIA 118 0.0548
126 PSEUDOMEMBRANOUS COLITIS 122 0.0546
127 BACTERAEMIA 645 0.0543
128 LUNG CONSOLIDATION 151 0.0539
129 SEPTIC SHOCK 2345 0.0538
130 MUCOSAL INFLAMMATION 1401 0.0535
131 DRUG LEVEL ABOVE THERAPEUTIC 243 0.0530
132 SPUTUM INCREASED 114 0.0527
133 ESCHERICHIA SEPSIS 152 0.0524
134 CYTOKINE RELEASE SYNDROME 1049 0.0522
135 DRUG INTERACTION 8235 0.0519
136 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 137 0.0515
137 TOXIC EPIDERMAL NECROLYSIS 773 0.0509
138 TUMOUR LYSIS SYNDROME 444 0.0504
139 RALES 293 0.0504
140 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 129 0.0499
141 LONG QT SYNDROME 118 0.0492
142 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 367 0.0489
143 ILEUS PARALYTIC 218 0.0488
144 BLOOD CULTURE POSITIVE 146 0.0487
145 BRONCHIECTASIS 325 0.0482
146 DRUG RESISTANCE 1219 0.0474
147 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 281 0.0474
148 HYPERBILIRUBINAEMIA 490 0.0473
149 PHOTOSENSITIVITY REACTION 773 0.0468
150 RHINOVIRUS INFECTION 182 0.0467
151 CLOSTRIDIUM DIFFICILE COLITIS 494 0.0465
152 OBSTRUCTIVE AIRWAYS DISORDER 518 0.0465
153 EPSTEIN-BARR VIRUS INFECTION 290 0.0464
154 MULTI-ORGAN FAILURE 797 0.0461
155 CHOLESTASIS 873 0.0454
156 ORAL FUNGAL INFECTION 124 0.0453
157 LUNG INFILTRATION 396 0.0448
158 MULTIPLE-DRUG RESISTANCE 139 0.0448
159 PANCYTOPENIA 2494 0.0446
160 END STAGE RENAL DISEASE 810 0.0444
161 IMMUNODEFICIENCY 658 0.0441
162 TRANSPLANT REJECTION 353 0.0440
163 HEPATOTOXICITY 976 0.0438
164 NEUROTOXICITY 763 0.0435
165 DIASTOLIC DYSFUNCTION 134 0.0434
166 DISSEMINATED INTRAVASCULAR COAGULATION 605 0.0429
167 POTENTIATING DRUG INTERACTION 143 0.0426
168 ADRENAL INSUFFICIENCY 509 0.0419
169 CUSHINGOID 134 0.0417
170 VAGINAL DISCHARGE 419 0.0414
171 ATELECTASIS 400 0.0414
172 NEPHROPATHY TOXIC 463 0.0412
173 LIVER ABSCESS 133 0.0410
174 MIXED LIVER INJURY 123 0.0408
175 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 155 0.0405
176 RENAL TUBULAR DISORDER 114 0.0405
177 ELECTROCARDIOGRAM QT PROLONGED 1456 0.0404
178 HYPOPHOSPHATAEMIA 298 0.0403
179 DRUG LEVEL DECREASED 403 0.0396
180 BRAIN HERNIATION 118 0.0395
181 HYPOALBUMINAEMIA 306 0.0393
182 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 200 0.0393
183 PULMONARY HAEMORRHAGE 302 0.0386
184 ONYCHOMYCOSIS 167 0.0380
185 THROMBOTIC MICROANGIOPATHY 367 0.0376
186 NAIL DISCOLOURATION 148 0.0376
187 ENDOPHTHALMITIS 223 0.0371
188 BLOOD LACTATE DEHYDROGENASE INCREASED 589 0.0371
189 CYTOPENIA 454 0.0370
190 HYPOKALAEMIA 1706 0.0369
191 VULVOVAGINAL MYCOTIC INFECTION 145 0.0368
192 FAILURE TO THRIVE 190 0.0366
193 VAGINAL INFECTION 172 0.0365
194 FULL BLOOD COUNT ABNORMAL 385 0.0364
195 HEPATIC CYTOLYSIS 461 0.0361
196 HYPOXIA 1266 0.0359
197 ARTERIOSCLEROSIS CORONARY ARTERY 236 0.0356
198 VASCULAR DEVICE INFECTION 160 0.0352
199 ACUTE RESPIRATORY DISTRESS SYNDROME 621 0.0351
200 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 191 0.0351
201 BLOOD BILIRUBIN INCREASED 948 0.0351
202 CACHEXIA 178 0.0346
203 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 304 0.0344
204 BONE MARROW FAILURE 695 0.0342
205 BLOOD ALKALINE PHOSPHATASE INCREASED 849 0.0342
206 HAEMOPTYSIS 951 0.0341
207 BACTERIAL INFECTION 636 0.0341
208 HEPATITIS CHOLESTATIC 205 0.0340
209 PNEUMONIA BACTERIAL 308 0.0335
210 HERPES SIMPLEX 218 0.0335
211 HALLUCINATION, VISUAL 707 0.0335
212 ENCEPHALITIS 230 0.0332
213 PULMONARY MASS 495 0.0332
214 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 168 0.0331
215 RESPIRATORY FAILURE 2412 0.0330
216 HYPOGAMMAGLOBULINAEMIA 215 0.0327
217 ESCHERICHIA INFECTION 268 0.0325
218 SQUAMOUS CELL CARCINOMA 306 0.0325
219 LEUKOENCEPHALOPATHY 121 0.0325
220 SEPSIS 3619 0.0324
221 HYPOMAGNESAEMIA 451 0.0324
222 HYPERTRANSAMINASAEMIA 223 0.0320
223 OLIGURIA 199 0.0320
224 THROMBOCYTOPENIA 3584 0.0320
225 SPUTUM DISCOLOURED 302 0.0318
226 STEVENS-JOHNSON SYNDROME 705 0.0317
227 PERIPHERAL SENSORY NEUROPATHY 185 0.0316
228 NEUTROPHIL COUNT DECREASED 1288 0.0316
229 CHRONIC KIDNEY DISEASE 2386 0.0314
230 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 299 0.0313
231 VASCULITIS 364 0.0312
232 RENAL TUBULAR NECROSIS 304 0.0310
233 DEVICE RELATED INFECTION 477 0.0310
234 TRANSAMINASES INCREASED 689 0.0310
235 SERUM FERRITIN INCREASED 162 0.0307
236 HAEMODYNAMIC INSTABILITY 232 0.0304
237 HYPERURICAEMIA 125 0.0304
238 RASH MACULO-PAPULAR 675 0.0303
239 SHOCK HAEMORRHAGIC 247 0.0303
240 STAPHYLOCOCCAL INFECTION 991 0.0300
241 ENTEROCOLITIS 173 0.0299
242 CHOLECYSTITIS CHRONIC 200 0.0298
243 BREATH SOUNDS ABNORMAL 147 0.0298
244 LEUKAEMIA 281 0.0297
245 HEPATIC FUNCTION ABNORMAL 1106 0.0296
246 ECONOMIC PROBLEM 445 0.0293
247 GAMMA-GLUTAMYLTRANSFERASE INCREASED 648 0.0292
248 ORGANISING PNEUMONIA 144 0.0290
249 AGRANULOCYTOSIS 540 0.0290
250 FEBRILE BONE MARROW APLASIA 123 0.0289
251 KIDNEY TRANSPLANT REJECTION 138 0.0287
252 MYOPATHY 248 0.0287
253 ELECTROLYTE IMBALANCE 330 0.0284
254 DRUG-INDUCED LIVER INJURY 891 0.0284
255 BURSITIS 344 0.0283
256 TRICUSPID VALVE INCOMPETENCE 225 0.0283
257 HYPERLIPIDAEMIA 338 0.0283
258 HEPATOCELLULAR INJURY 401 0.0283
259 PROTHROMBIN TIME PROLONGED 169 0.0282
260 ASPIRATION 309 0.0282
261 ENCEPHALOPATHY 692 0.0282
262 LUNG INFECTION 434 0.0279
263 LYMPHOPENIA 395 0.0279
264 BLOOD ALBUMIN DECREASED 221 0.0278
265 DERMATITIS EXFOLIATIVE 139 0.0278
266 ACUTE RESPIRATORY FAILURE 534 0.0277
267 MYOSITIS 249 0.0277
268 SUBCUTANEOUS ABSCESS 133 0.0277
269 ACUTE KIDNEY INJURY 4190 0.0274
270 DERMATITIS BULLOUS 198 0.0273
271 NECROSIS 152 0.0273
272 ORAL DISORDER 200 0.0273
273 HALLUCINATIONS, MIXED 114 0.0271
274 ECCHYMOSIS 185 0.0270
275 RENAL FAILURE ACUTE 1140 0.0268
276 PLEURAL EFFUSION 1630 0.0268
277 MYELODYSPLASTIC SYNDROME 387 0.0267
278 NEUTROPENIA 3633 0.0267
279 HEPATOMEGALY 262 0.0266
280 SKIN INFECTION 299 0.0266
281 COELIAC DISEASE 261 0.0266
282 ANHEDONIA 699 0.0266
283 LYMPHOCYTE COUNT DECREASED 470 0.0266
284 ARTERIOSCLEROSIS 248 0.0263
285 HYPERNATRAEMIA 131 0.0263
286 INTRACRANIAL PRESSURE INCREASED 146 0.0262
287 CHEILITIS 141 0.0260
288 PNEUMOCYSTIS JIROVECII PNEUMONIA 261 0.0260
289 ASPARTATE AMINOTRANSFERASE INCREASED 1379 0.0259
290 PULMONARY FIBROSIS 497 0.0259
291 MULTIPLE MYELOMA 120 0.0257
292 LIVER FUNCTION TEST ABNORMAL 747 0.0257
293 SKIN NECROSIS 133 0.0256
294 BLOOD UREA INCREASED 429 0.0256
295 TOXIC SKIN ERUPTION 258 0.0256
296 CHOLECYSTITIS ACUTE 145 0.0256
297 UPPER RESPIRATORY TRACT INFECTION 1179 0.0255
298 RENAL FAILURE 3373 0.0254
299 PLATELET COUNT DECREASED 2689 0.0252
300 BLOOD CALCIUM INCREASED 221 0.0252
301 ALANINE AMINOTRANSFERASE INCREASED 1546 0.0252
302 PRESCRIBED OVERDOSE 487 0.0251
303 COAGULOPATHY 417 0.0250
304 HYPERCALCAEMIA 309 0.0250
305 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 256 0.0249
306 IMMUNOSUPPRESSION 219 0.0248
307 BENIGN PROSTATIC HYPERPLASIA 128 0.0248
308 BRAIN OEDEMA 313 0.0248
309 BLOOD CREATININE INCREASED 1594 0.0244
310 MALNUTRITION 272 0.0243
311 ODYNOPHAGIA 145 0.0243
312 C-REACTIVE PROTEIN INCREASED 878 0.0241
313 PARAESTHESIA ORAL 346 0.0240
314 MOUTH ULCERATION 505 0.0239
315 HYPERKALAEMIA 840 0.0239
316 HEPATIC FAILURE 720 0.0239
317 PNEUMOTHORAX 377 0.0237
318 MALABSORPTION 124 0.0237
319 ILEUS 295 0.0237
320 MENINGITIS 158 0.0236
321 GENERALISED OEDEMA 292 0.0236
322 SPINAL OSTEOARTHRITIS 207 0.0235
323 BLOOD URIC ACID INCREASED 136 0.0235
324 OESOPHAGITIS 257 0.0235
325 TACHYPNOEA 319 0.0234
326 INTERNATIONAL NORMALISED RATIO INCREASED 667 0.0234
327 MENTAL STATUS CHANGES 649 0.0233
328 LEUKOPENIA 1167 0.0233
329 DYSLIPIDAEMIA 118 0.0232
330 ENDOCARDITIS 119 0.0232
331 PETECHIAE 242 0.0232
332 CARDIAC FAILURE ACUTE 154 0.0231
333 STREPTOCOCCAL INFECTION 128 0.0230
334 ACUTE PULMONARY OEDEMA 129 0.0230
335 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1258 0.0229
336 LEFT VENTRICULAR DYSFUNCTION 153 0.0228
337 BLOOD MAGNESIUM DECREASED 197 0.0228
338 DIVERTICULUM 162 0.0228
339 SKIN LESION 622 0.0227
340 DELIRIUM 786 0.0226
341 VENTRICULAR TACHYCARDIA 373 0.0226
342 DRUG ERUPTION 399 0.0225
343 HYPERTRIGLYCERIDAEMIA 131 0.0224
344 HOSPICE CARE 221 0.0224
345 RHABDOMYOLYSIS 930 0.0223
346 PYREXIA 7688 0.0222
347 LEUKOCYTOSIS 402 0.0222
348 HAEMODIALYSIS 186 0.0221
349 HYDROCEPHALUS 120 0.0220
350 RESPIRATORY DISTRESS 604 0.0219
351 ACIDOSIS 167 0.0218
352 DECUBITUS ULCER 178 0.0218
353 RESPIRATORY SYNCYTIAL VIRUS INFECTION 190 0.0218
354 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 560 0.0217
355 TUBULOINTERSTITIAL NEPHRITIS 407 0.0217
356 HYPONATRAEMIA 1223 0.0217
357 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 168 0.0216
358 DIFFUSE LARGE B-CELL LYMPHOMA 166 0.0215
359 HYPERCHOLESTEROLAEMIA 208 0.0215
360 RENAL FAILURE CHRONIC 164 0.0213
361 RENAL IMPAIRMENT 1788 0.0213
362 NODULE 277 0.0212
363 HAIR TEXTURE ABNORMAL 283 0.0211
364 ANURIA 182 0.0211
365 OSTEOPENIA 320 0.0211
366 HAEMATOCRIT DECREASED 415 0.0209
367 SINUS TACHYCARDIA 297 0.0209
368 SUPRAVENTRICULAR TACHYCARDIA 200 0.0209
369 ERYTHEMA MULTIFORME 194 0.0208
370 HYDRONEPHROSIS 155 0.0207
371 PERICARDIAL EFFUSION 478 0.0207
372 HERPES VIRUS INFECTION 119 0.0206
373 VENTRICULAR FIBRILLATION 229 0.0206
374 HEPATITIS ACUTE 134 0.0206
375 TRANSFUSION 216 0.0206
376 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 350 0.0206
377 PAPULE 145 0.0206
378 RASH ERYTHEMATOUS 980 0.0205
379 EOSINOPHILIA 359 0.0205
380 INTERVERTEBRAL DISC DEGENERATION 189 0.0204
381 MITRAL VALVE INCOMPETENCE 231 0.0204
382 VENTRICULAR EXTRASYSTOLES 211 0.0203
383 ATRIAL FLUTTER 161 0.0202
384 ASCITES 591 0.0201
385 ANAEMIA 3823 0.0200
386 ENTERITIS 128 0.0200
387 COLITIS 758 0.0200
388 PROCTALGIA 128 0.0199
389 CELLULITIS 992 0.0197
390 CARDIOTOXICITY 175 0.0196
391 HEPATIC ENZYME INCREASED 1336 0.0196
392 CLOSTRIDIUM DIFFICILE INFECTION 427 0.0195
393 SINUS BRADYCARDIA 189 0.0195
394 UROSEPSIS 180 0.0195
395 SPLENOMEGALY 228 0.0194
396 LARGE INTESTINE PERFORATION 135 0.0194
397 JAUNDICE 523 0.0194
398 PRE-EXISTING CONDITION IMPROVED 121 0.0194
399 RENAL INJURY 570 0.0192
400 PNEUMONITIS 518 0.0190
401 LIVER FUNCTION TEST INCREASED 405 0.0188
402 LIVER DISORDER 836 0.0188
403 WHITE BLOOD CELL COUNT DECREASED 2034 0.0187
404 PURPURA 166 0.0187
405 INFECTION 2715 0.0187
406 PNEUMONIA 6057 0.0187
407 NEPHROPATHY 174 0.0186
408 CARDIOMEGALY 227 0.0184
409 OSTEOMYELITIS 334 0.0184
410 IRON DEFICIENCY ANAEMIA 170 0.0184
411 ABSCESS 292 0.0183
412 ALTERED STATE OF CONSCIOUSNESS 396 0.0183
413 LIPASE INCREASED 140 0.0183
414 PRODUCT ADMINISTRATION INTERRUPTED 143 0.0182
415 SHOCK 418 0.0182
416 EMPHYSEMA 183 0.0181
417 LIVER INJURY 444 0.0181
418 BLOOD TEST ABNORMAL 254 0.0181
419 VITAMIN D DEFICIENCY 176 0.0180
420 MYELOSUPPRESSION 646 0.0179
421 HAEMATOTOXICITY 170 0.0179
422 COVID-19 PNEUMONIA 210 0.0178
423 HYPERGLYCAEMIA 648 0.0178
424 METABOLIC ACIDOSIS 568 0.0177
425 TREATMENT FAILURE 1471 0.0177
426 HAEMOLYTIC ANAEMIA 159 0.0177
427 LUNG DISORDER 868 0.0177
428 PANCREATITIS ACUTE 398 0.0177
429 HALLUCINATION 1331 0.0176
430 CONTRAINDICATED PRODUCT ADMINISTERED 534 0.0176
431 CHOLECYSTITIS 210 0.0176
432 DERMATITIS 365 0.0174
433 PHARYNGITIS 216 0.0174
434 HAEMOLYSIS 134 0.0173
435 HEPATITIS 443 0.0173
436 HIATUS HERNIA 224 0.0173
437 TOOTH ABSCESS 175 0.0172
438 ORTHOSTATIC HYPOTENSION 298 0.0171
439 MYOCLONUS 204 0.0171
440 STOMATITIS 1035 0.0170
441 TENDERNESS 177 0.0170
442 SWOLLEN TONGUE 530 0.0170
443 HICCUPS 139 0.0169
444 URINE OUTPUT DECREASED 148 0.0169
445 DEEP VEIN THROMBOSIS 1097 0.0169
446 SLEEP APNOEA SYNDROME 322 0.0169
447 TROPONIN INCREASED 128 0.0168
448 INFUSION RELATED REACTION 1113 0.0168
449 BASAL CELL CARCINOMA 261 0.0167
450 SKIN HYPERPIGMENTATION 143 0.0166
451 DISEASE PROGRESSION 1956 0.0165
452 HAEMATURIA 565 0.0165
453 SEASONAL ALLERGY 233 0.0164
454 BLOOD SODIUM DECREASED 310 0.0164
455 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1167 0.0164
456 DRUG TOXICITY 223 0.0164
457 FLUID OVERLOAD 237 0.0163
458 HAEMOGLOBIN DECREASED 1672 0.0163
459 NAIL DISORDER 142 0.0162
460 BLOOD POTASSIUM DECREASED 488 0.0162
461 DERMATITIS CONTACT 185 0.0162
462 SPINAL COMPRESSION FRACTURE 134 0.0162
463 ACUTE HEPATIC FAILURE 221 0.0162
464 ORAL PAIN 362 0.0162
465 OEDEMA 871 0.0160
466 RED BLOOD CELL COUNT DECREASED 459 0.0160
467 RENAL CYST 127 0.0160
468 HYPOTHYROIDISM 509 0.0159
469 FULL BLOOD COUNT DECREASED 321 0.0159
470 MULTIPLE ALLERGIES 124 0.0158
471 BONE DISORDER 287 0.0157
472 HYPOCALCAEMIA 298 0.0157
473 PRODUCTIVE COUGH 749 0.0157
474 NEUROPATHY PERIPHERAL 1490 0.0156
475 LOWER RESPIRATORY TRACT INFECTION 712 0.0156
476 SKIN PLAQUE 132 0.0156
477 OEDEMA PERIPHERAL 1906 0.0156
478 HAEMORRHOIDS 305 0.0156
479 PRODUCT USE IN UNAPPROVED INDICATION 3875 0.0156
480 CARDIAC MURMUR 135 0.0156
481 LYMPHADENOPATHY 549 0.0155
482 GASTROENTERITIS 226 0.0155
483 IMPAIRED GASTRIC EMPTYING 210 0.0154
484 PULMONARY EMBOLISM 1462 0.0154
485 OSTEOPOROSIS 632 0.0153
486 SKIN LACERATION 165 0.0152
487 PULMONARY OEDEMA 679 0.0151
488 CONJUNCTIVITIS 281 0.0151
489 BLOOD CALCIUM DECREASED 170 0.0151
490 BLISTER 849 0.0151
491 HEMIPARESIS 256 0.0151
492 SKIN ULCER 388 0.0150
493 CONDITION AGGRAVATED 4551 0.0150
494 ASTHMA 1691 0.0149
495 SUBARACHNOID HAEMORRHAGE 152 0.0149
496 RESPIRATORY TRACT INFECTION 388 0.0149
497 PHOTOPHOBIA 280 0.0149
498 FOLLICULITIS 156 0.0149
499 FLANK PAIN 139 0.0148
500 CYSTITIS 472 0.0148
501 STATUS EPILEPTICUS 167 0.0148
502 ORAL HERPES 288 0.0147
503 HYPOPHAGIA 376 0.0147
504 RESPIRATORY DISORDER 439 0.0147
505 EMBOLISM 121 0.0146
506 WHEEZING 864 0.0146
507 BODY TEMPERATURE INCREASED 297 0.0145
508 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 120 0.0145
509 WHITE BLOOD CELL COUNT INCREASED 555 0.0145
510 PNEUMONIA ASPIRATION 361 0.0144
511 CHOLELITHIASIS 472 0.0144
512 INFUSION SITE ERYTHEMA 121 0.0143
513 BLOOD POTASSIUM INCREASED 232 0.0143
514 EXPOSURE DURING PREGNANCY 888 0.0143
515 EJECTION FRACTION DECREASED 222 0.0143
516 CENTRAL NERVOUS SYSTEM LESION 196 0.0143
517 PULMONARY CONGESTION 188 0.0142
518 NEURALGIA 346 0.0142
519 SCAB 162 0.0142
520 RECTAL HAEMORRHAGE 610 0.0142
521 FLUID RETENTION 721 0.0142
522 HEPATIC STEATOSIS 264 0.0142
523 NEUTROPHIL COUNT INCREASED 145 0.0141
524 THERAPY NON-RESPONDER 634 0.0141
525 SKIN DISORDER 470 0.0141
526 DRUG INTOLERANCE 1359 0.0141
527 UPPER GASTROINTESTINAL HAEMORRHAGE 236 0.0140
528 SECRETION DISCHARGE 175 0.0140
529 CARDIAC ARREST 1150 0.0139
530 DEPRESSED LEVEL OF CONSCIOUSNESS 550 0.0139
531 ATRIAL FIBRILLATION 1352 0.0139
532 PYELONEPHRITIS 120 0.0138
533 HAEMORRHAGE INTRACRANIAL 207 0.0138
534 ATAXIA 164 0.0138
535 CARDIOMYOPATHY 204 0.0138
536 DYSURIA 508 0.0138
537 SINUSITIS 1408 0.0137
538 GALLBLADDER DISORDER 245 0.0137
539 CARDIAC FAILURE 1099 0.0137
540 HAEMATOMA 353 0.0136
541 URINARY TRACT INFECTION 2324 0.0136
542 GASTROINTESTINAL INFECTION 122 0.0136
543 CARDIOGENIC SHOCK 195 0.0136
544 SEROTONIN SYNDROME 261 0.0136
545 FREQUENT BOWEL MOVEMENTS 367 0.0136
546 NERVOUS SYSTEM DISORDER 424 0.0136
547 POLYNEUROPATHY 162 0.0135
548 HAIR COLOUR CHANGES 168 0.0135
549 TOOTH INFECTION 177 0.0134
550 HEPATIC ENCEPHALOPATHY 125 0.0134
551 SKIN EXFOLIATION 1127 0.0133
552 LYMPHOMA 206 0.0133
553 CEREBRAL HAEMORRHAGE 475 0.0133
554 SWELLING FACE 863 0.0132
555 GASTROOESOPHAGEAL REFLUX DISEASE 1063 0.0132
556 CONSTIPATION 2876 0.0132
557 HYPOTENSION 2634 0.0131
558 TACHYCARDIA 1166 0.0131
559 FACIAL PAIN 117 0.0131
560 DYSPNOEA EXERTIONAL 489 0.0130
561 DEHYDRATION 1730 0.0130
562 PLASMA CELL MYELOMA 505 0.0129
563 IMPAIRED QUALITY OF LIFE 186 0.0129
564 GENERALISED TONIC-CLONIC SEIZURE 214 0.0129
565 INTESTINAL PERFORATION 145 0.0129
566 PULMONARY HYPERTENSION 269 0.0129
567 VIRAL INFECTION 428 0.0128
568 DYSPHAGIA 1219 0.0128
569 DIALYSIS 182 0.0128
570 MICTURITION URGENCY 146 0.0128
571 DECREASED IMMUNE RESPONSIVENESS 125 0.0127
572 URINARY INCONTINENCE 377 0.0127
573 CIRCULATORY COLLAPSE 216 0.0127
574 OSTEOARTHRITIS 536 0.0126
575 OXYGEN SATURATION DECREASED 710 0.0126
576 SUBDURAL HAEMATOMA 180 0.0126
577 DENTAL CARIES 139 0.0126
578 OFF LABEL USE 10997 0.0125
579 CEREBRAL INFARCTION 306 0.0125
580 SINUS CONGESTION 169 0.0125
581 MELAENA 274 0.0124
582 RENAL DISORDER 580 0.0124
583 WOUND INFECTION 136 0.0124
584 ANOREXIA 160 0.0124
585 FACE OEDEMA 209 0.0124
586 GRAND MAL CONVULSION 114 0.0123
587 MUSCULOSKELETAL CHEST PAIN 191 0.0123
588 GENERAL PHYSICAL HEALTH DETERIORATION 1425 0.0123
589 NO THERAPEUTIC RESPONSE 150 0.0123
590 DYSPHONIA 719 0.0123
591 INTERSTITIAL LUNG DISEASE 594 0.0123
592 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 640 0.0123
593 BRADYCARDIA 647 0.0122
594 EAR PAIN 237 0.0122
595 UVEITIS 164 0.0121
596 DISEASE RECURRENCE 574 0.0121
597 GASTRITIS 317 0.0120
598 SMALL INTESTINAL OBSTRUCTION 148 0.0120
599 BRONCHITIS 890 0.0120
600 IMMUNE SYSTEM DISORDER 158 0.0120
601 ABDOMINAL PAIN 2788 0.0120
602 SCIATICA 191 0.0120
603 SINUS DISORDER 237 0.0120
604 CONFUSIONAL STATE 1925 0.0119
605 PRODUCT USE ISSUE 2217 0.0118
606 FOOT FRACTURE 223 0.0118
607 MUSCLE ATROPHY 149 0.0117
608 HAEMATOCHEZIA 648 0.0117
609 THERAPY PARTIAL RESPONDER 183 0.0117
610 ERYTHEMA 2408 0.0117
611 APHASIA 352 0.0116
612 PROCEDURAL PAIN 323 0.0116
613 PERITONITIS 241 0.0116
614 OBESITY 185 0.0116
615 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 557 0.0116
616 RED BLOOD CELL SEDIMENTATION RATE INCREASED 128 0.0116
617 INFUSION SITE PAIN 149 0.0116
618 HERPES ZOSTER 662 0.0115
619 CHROMATURIA 260 0.0115
620 GASTROINTESTINAL HAEMORRHAGE 962 0.0115
621 EPISTAXIS 859 0.0115
622 ROTATOR CUFF SYNDROME 147 0.0114
623 RIB FRACTURE 235 0.0114
624 BLOOD CREATINE PHOSPHOKINASE INCREASED 328 0.0114
625 HYPERTENSION 2392 0.0113
626 GOUT 201 0.0112
627 UNRESPONSIVE TO STIMULI 289 0.0112
628 ULCER 178 0.0112
629 DRUG INEFFECTIVE 14692 0.0111
630 BLOOD COUNT ABNORMAL 169 0.0111
631 INJURY 780 0.0111
632 EYE INFECTION 125 0.0111
633 RASH 4823 0.0111
634 NERVE INJURY 122 0.0110
635 ANGIOEDEMA 484 0.0109
636 HALLUCINATION, AUDITORY 173 0.0109
637 HAEMATEMESIS 276 0.0109
638 QUALITY OF LIFE DECREASED 146 0.0109
639 BLOOD TRIGLYCERIDES INCREASED 192 0.0109
640 MUSCULAR WEAKNESS 1231 0.0108
641 DYSPEPSIA 1062 0.0108
642 GASTRIC ULCER 205 0.0108
643 MULTIPLE FRACTURES 177 0.0108
644 RESPIRATORY DEPRESSION 132 0.0108
645 CHILLS 1261 0.0107
646 DIVERTICULITIS 297 0.0107
647 ARRHYTHMIA 507 0.0107
648 SCAR 183 0.0107
649 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 183 0.0107
650 LOCALISED INFECTION 258 0.0107
651 BRAIN FOG 167 0.0106
652 DECREASED APPETITE 2474 0.0106
653 CORONARY ARTERY DISEASE 320 0.0106
654 INTERVERTEBRAL DISC PROTRUSION 230 0.0105
655 PANCREATITIS 555 0.0105
656 DIABETES MELLITUS 800 0.0105
657 DERMATITIS ALLERGIC 132 0.0105
658 PROTEINURIA 199 0.0105
659 NOCTURIA 127 0.0105
660 BLOOD PRESSURE SYSTOLIC INCREASED 204 0.0104
661 LIP SWELLING 345 0.0103
662 PLATELET COUNT INCREASED 135 0.0103
663 FEEDING DISORDER 210 0.0103
664 CONVULSION 591 0.0103
665 HYPOGLYCAEMIA 501 0.0103
666 CARDIO-RESPIRATORY ARREST 431 0.0103
667 DIARRHOEA 6617 0.0102
668 RASH GENERALISED 265 0.0102
669 COUGH 2868 0.0102
670 LETHARGY 587 0.0102
671 MENTAL DISORDER 444 0.0102
672 GINGIVAL BLEEDING 139 0.0102
673 APPLICATION SITE PAIN 224 0.0102
674 TOOTHACHE 184 0.0102
675 BRONCHOSPASM 145 0.0102
676 HYPERSENSITIVITY 1873 0.0101
677 MASS 141 0.0101
678 RASH PRURITIC 545 0.0100
679 URINARY RETENTION 333 0.0100
680 PSORIASIS 1303 0.0100
681 DISORIENTATION 394 0.0099
682 WEIGHT DECREASED 2769 0.0099
683 THROMBOSIS 798 0.0099
684 ASTHENIA 3705 0.0098
685 EAR INFECTION 262 0.0098
686 GASTROINTESTINAL DISORDER 879 0.0098
687 BONE DENSITY DECREASED 307 0.0098
688 DEAFNESS 254 0.0097
689 GLAUCOMA 187 0.0097
690 CARDIAC FAILURE CONGESTIVE 779 0.0097
691 RASH MACULAR 339 0.0097
692 BACK PAIN 2243 0.0096
693 ORAL DISCOMFORT 134 0.0096
694 DYSPNOEA 5446 0.0096
695 PHARYNGEAL OEDEMA 148 0.0096
696 EPILEPSY 294 0.0096
697 OROPHARYNGEAL PAIN 888 0.0096
698 CYST 119 0.0096
699 SKIN REACTION 135 0.0096
700 CARPAL TUNNEL SYNDROME 134 0.0096
701 ANXIETY 2719 0.0095
702 TREMOR 1584 0.0095
703 TASTE DISORDER 193 0.0095
704 BONE PAIN 556 0.0095
705 JOINT SWELLING 1144 0.0095
706 RASH PAPULAR 212 0.0094
707 DYSARTHRIA 353 0.0094
708 FAECES DISCOLOURED 203 0.0094
709 ACUTE MYOCARDIAL INFARCTION 276 0.0094
710 EYE PAIN 528 0.0093
711 VOMITING 4388 0.0093
712 ECZEMA 488 0.0093
713 INFLAMMATION 481 0.0093
714 ANKLE FRACTURE 144 0.0093
715 GLOMERULAR FILTRATION RATE DECREASED 114 0.0093
716 SYNCOPE 927 0.0093
717 TENDONITIS 143 0.0092
718 ABORTION SPONTANEOUS 370 0.0092
719 COMA 438 0.0092
720 NEPHROLITHIASIS 421 0.0092
721 ABDOMINAL DISTENSION 958 0.0092
722 POST PROCEDURAL COMPLICATION 175 0.0091
723 POLLAKIURIA 380 0.0091
724 NIGHT SWEATS 293 0.0091
725 CYANOSIS 143 0.0091
726 DIPLOPIA 236 0.0091
727 OSTEONECROSIS OF JAW 224 0.0090
728 LACTIC ACIDOSIS 293 0.0090
729 HAEMORRHAGE 945 0.0090
730 CHEST PAIN 1665 0.0090
731 COLITIS ULCERATIVE 400 0.0089
732 NAUSEA 7070 0.0089
733 AGITATION 654 0.0089
734 VAGINAL HAEMORRHAGE 386 0.0089
735 TREATMENT NONCOMPLIANCE 483 0.0088
736 OSTEONECROSIS 289 0.0088
737 BLOOD PRESSURE DECREASED 583 0.0088
738 SKIN HAEMORRHAGE 130 0.0088
739 ABDOMINAL PAIN LOWER 221 0.0087
740 EMOTIONAL DISTRESS 1058 0.0087
741 JOINT RANGE OF MOTION DECREASED 117 0.0087
742 INSURANCE ISSUE 133 0.0087
743 INTENTIONAL PRODUCT MISUSE 761 0.0087
744 PAIN 5327 0.0087
745 PRESYNCOPE 210 0.0086
746 NECK PAIN 482 0.0086
747 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 201 0.0086
748 JOINT INJURY 184 0.0086
749 PAIN IN JAW 244 0.0086
750 HEADACHE 5400 0.0086
751 CONTUSION 829 0.0086
752 SKIN DISCOLOURATION 393 0.0085
753 BURNING SENSATION 599 0.0085
754 SWELLING 799 0.0085
755 KIDNEY INFECTION 167 0.0085
756 VISUAL IMPAIRMENT 1052 0.0085
757 HYPERHIDROSIS 1087 0.0084
758 VISUAL ACUITY REDUCED 280 0.0084
759 PELVIC PAIN 153 0.0084
760 NEOPLASM PROGRESSION 292 0.0084
761 LABORATORY TEST ABNORMAL 247 0.0084
762 RETCHING 178 0.0083
763 PERIPHERAL SWELLING 1278 0.0083
764 CHEST DISCOMFORT 849 0.0083
765 IMPAIRED HEALING 272 0.0083
766 PRURITUS 3171 0.0082
767 TOOTH DISORDER 183 0.0082
768 INTENTIONAL PRODUCT USE ISSUE 720 0.0082
769 FIBROMYALGIA 199 0.0082
770 TRANSIENT ISCHAEMIC ATTACK 276 0.0082
771 SLEEP DISORDER 577 0.0082
772 LIMB INJURY 222 0.0082
773 HYPOAESTHESIA ORAL 123 0.0082
774 FATIGUE 6334 0.0081
775 MUSCULOSKELETAL DISCOMFORT 140 0.0081
776 HYPOAESTHESIA 1217 0.0081
777 HYPERSOMNIA 233 0.0081
778 DRY MOUTH 658 0.0081
779 MYALGIA 1377 0.0081
780 CATARACT 482 0.0081
781 DIABETES MELLITUS INADEQUATE CONTROL 143 0.0081
782 ALOPECIA 1585 0.0081
783 BLOOD URINE PRESENT 153 0.0081
784 HEPATIC CIRRHOSIS 151 0.0080
785 DEPRESSION 1828 0.0080
786 TOXICITY TO VARIOUS AGENTS 1353 0.0080
787 TYPE 2 DIABETES MELLITUS 269 0.0080
788 VISION BLURRED 1097 0.0080
789 SENSORY DISTURBANCE 128 0.0080
790 BLOOD CHOLESTEROL INCREASED 371 0.0080
791 ARTHRITIS 621 0.0079
792 LOSS OF CONSCIOUSNESS 1010 0.0079
793 GASTROENTERITIS VIRAL 142 0.0079
794 INFLUENZA 873 0.0078
795 COGNITIVE DISORDER 365 0.0078
796 BALANCE DISORDER 675 0.0078
797 MUSCULOSKELETAL PAIN 407 0.0078
798 POOR QUALITY SLEEP 167 0.0077
799 ISCHAEMIC STROKE 138 0.0077
800 THERAPEUTIC RESPONSE UNEXPECTED 346 0.0077
801 BLOOD PRESSURE FLUCTUATION 184 0.0077
802 HEART RATE INCREASED 756 0.0076
803 PRODUCT PRESCRIBING ISSUE 166 0.0076
804 INTESTINAL OBSTRUCTION 287 0.0076
805 IRRITABLE BOWEL SYNDROME 163 0.0076
806 HEART RATE IRREGULAR 171 0.0076
807 ABDOMINAL PAIN UPPER 1552 0.0075
808 RHINORRHOEA 487 0.0075
809 SOMNOLENCE 1517 0.0075
810 SKIN FISSURES 147 0.0075
811 PAIN IN EXTREMITY 2209 0.0075
812 BLOOD PRESSURE ABNORMAL 149 0.0075
813 EATING DISORDER 159 0.0075
814 SEIZURE 860 0.0074
815 COVID-19 1306 0.0074
816 PREMATURE BABY 224 0.0074
817 WOUND 208 0.0074
818 METASTASES TO BONE 122 0.0074
819 LOCAL SWELLING 129 0.0074
820 DRY EYE 368 0.0074
821 SKIN CANCER 158 0.0073
822 FALL 2415 0.0072
823 EYE SWELLING 268 0.0072
824 NASAL CONGESTION 423 0.0072
825 DYSSTASIA 210 0.0072
826 SPINAL FRACTURE 144 0.0072
827 RESTLESSNESS 263 0.0072
828 LACRIMATION INCREASED 217 0.0072
829 MUSCULOSKELETAL STIFFNESS 628 0.0072
830 RESTLESS LEGS SYNDROME 130 0.0071
831 TOOTH LOSS 147 0.0071
832 TINNITUS 325 0.0071
833 HEART RATE DECREASED 248 0.0071
834 SPEECH DISORDER 370 0.0071
835 DRUG EXPOSURE DURING PREGNANCY 240 0.0070
836 PARAESTHESIA 1110 0.0070
837 ANGINA PECTORIS 202 0.0070
838 FLATULENCE 397 0.0070
839 MALAISE 3063 0.0070
840 PALLOR 190 0.0070
841 PSORIATIC ARTHROPATHY 283 0.0070
842 ABASIA 171 0.0069
843 HEAD INJURY 219 0.0069
844 PALPITATIONS 807 0.0069
845 THIRST 123 0.0069
846 EYE DISORDER 226 0.0069
847 MUSCLE SPASMS 1258 0.0068
848 DISCOMFORT 418 0.0068
849 DERMATITIS ATOPIC 361 0.0068
850 BLOOD PRESSURE INCREASED 1040 0.0068
851 DYSKINESIA 276 0.0068
852 PERICARDITIS 114 0.0068
853 WEIGHT INCREASED 1518 0.0068
854 MOBILITY DECREASED 487 0.0068
855 GAIT DISTURBANCE 1296 0.0068
856 INSOMNIA 1799 0.0067
857 DRY SKIN 894 0.0067
858 OCULAR HYPERAEMIA 317 0.0067
859 MALIGNANT NEOPLASM PROGRESSION 682 0.0067
860 ARTHRALGIA 2751 0.0066
861 ACTIVITIES OF DAILY LIVING IMPAIRED 131 0.0066
862 INTENTIONAL DOSE OMISSION 188 0.0066
863 ANAPHYLACTIC REACTION 364 0.0066
864 DIZZINESS 3277 0.0066
865 ARTHROPATHY 364 0.0065
866 METASTASES TO LIVER 115 0.0065
867 DIABETIC KETOACIDOSIS 157 0.0065
868 AGEUSIA 163 0.0065
869 BLINDNESS 266 0.0065
870 JOINT STIFFNESS 171 0.0065
871 PAIN OF SKIN 175 0.0065
872 HIP FRACTURE 209 0.0065
873 THERAPEUTIC RESPONSE DECREASED 394 0.0065
874 UPPER LIMB FRACTURE 129 0.0065
875 SKIN IRRITATION 295 0.0064
876 PRURITUS GENERALISED 139 0.0064
877 DEATH 5514 0.0064
878 AMNESIA 415 0.0064
879 RHEUMATOID ARTHRITIS 724 0.0064
880 THROAT TIGHTNESS 172 0.0064
881 RESPIRATORY ARREST 175 0.0063
882 URTICARIA 1060 0.0063
883 MIGRAINE 603 0.0063
884 HERNIA 122 0.0063
885 HOSPITALISATION 963 0.0063
886 PANIC ATTACK 228 0.0062
887 SURGERY 366 0.0062
888 ABDOMINAL DISCOMFORT 1047 0.0062
889 VERTIGO 379 0.0062
890 MENTAL IMPAIRMENT 150 0.0062
891 CARDIOVASCULAR DISORDER 157 0.0062
892 ILLNESS 637 0.0062
893 DISABILITY 122 0.0062
894 MUSCLE TWITCHING 141 0.0061
895 GLOSSODYNIA 136 0.0061
896 LIMB DISCOMFORT 186 0.0060
897 NASOPHARYNGITIS 1107 0.0060
898 PRESCRIBED UNDERDOSE 119 0.0060
899 UNEVALUABLE EVENT 451 0.0060
900 THROAT IRRITATION 267 0.0059
901 ABNORMAL BEHAVIOUR 234 0.0059
902 APPLICATION SITE ERYTHEMA 153 0.0058
903 DYSGEUSIA 433 0.0058
904 ERECTILE DYSFUNCTION 148 0.0058
905 PRODUCT DOSE OMISSION IN ERROR 163 0.0058
906 DISTURBANCE IN ATTENTION 310 0.0057
907 FEELING COLD 160 0.0057
908 PRODUCT DOSE OMISSION ISSUE 1686 0.0057
909 MATERNAL EXPOSURE DURING PREGNANCY 510 0.0057
910 PSYCHOTIC DISORDER 168 0.0057
911 EYE PRURITUS 191 0.0057
912 SYSTEMIC LUPUS ERYTHEMATOSUS 198 0.0056
913 HYPOACUSIS 240 0.0056
914 GAIT INABILITY 186 0.0056
915 PRODUCT PRESCRIBING ERROR 131 0.0055
916 ADVERSE DRUG REACTION 493 0.0055
917 FEAR 147 0.0055
918 APPLICATION SITE PRURITUS 123 0.0054
919 MEDICATION ERROR 300 0.0054
920 MOVEMENT DISORDER 173 0.0054
921 MEMORY IMPAIRMENT 734 0.0053
922 EYE IRRITATION 306 0.0053
923 SNEEZING 119 0.0053
924 ILL-DEFINED DISORDER 321 0.0053
925 DEPRESSED MOOD 278 0.0053
926 INFLUENZA LIKE ILLNESS 431 0.0052
927 FEMUR FRACTURE 161 0.0052
928 PRODUCT AVAILABILITY ISSUE 118 0.0052
929 PRODUCT DOSE OMISSION 333 0.0051
930 GASTRIC DISORDER 175 0.0051
931 FOETAL EXPOSURE DURING PREGNANCY 414 0.0051
932 DRUG EFFECT INCOMPLETE 184 0.0051
933 THERAPY INTERRUPTED 362 0.0051
934 HOT FLUSH 378 0.0050
935 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 899 0.0050
936 CARDIAC DISORDER 463 0.0049
937 ADVERSE EVENT 454 0.0049
938 SEDATION 128 0.0049
939 NEOPLASM MALIGNANT 322 0.0048
940 SUICIDAL IDEATION 441 0.0048
941 FEELING ABNORMAL 1153 0.0048
942 EMOTIONAL DISORDER 147 0.0048
943 OVERDOSE 1028 0.0048
944 DEMENTIA 133 0.0048
945 CEREBROVASCULAR ACCIDENT 794 0.0047
946 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 137 0.0047
947 NIGHTMARE 161 0.0046
948 NERVOUSNESS 242 0.0046
949 ROAD TRAFFIC ACCIDENT 193 0.0046
950 THERAPEUTIC RESPONSE SHORTENED 151 0.0045
951 MOOD ALTERED 124 0.0045
952 BLOOD GLUCOSE DECREASED 217 0.0045
953 FEELING HOT 276 0.0045
954 AGGRESSION 225 0.0045
955 TARDIVE DYSKINESIA 124 0.0044
956 ABNORMAL DREAMS 121 0.0044
957 BLOOD GLUCOSE INCREASED 820 0.0043
958 EXPIRED PRODUCT ADMINISTERED 143 0.0043
959 ACCIDENTAL OVERDOSE 155 0.0042
960 THERAPY CESSATION 217 0.0042
961 THERAPEUTIC PRODUCT EFFECT DECREASED 189 0.0042
962 MOOD SWINGS 130 0.0041
963 FLUSHING 410 0.0040
964 MYOCARDIAL INFARCTION 694 0.0040
965 ACNE 285 0.0038
966 UNDERDOSE 274 0.0037
967 DRUG ADMINISTRATION ERROR 114 0.0037
968 CRYING 134 0.0037
969 IRRITABILITY 214 0.0036
970 SKIN BURNING SENSATION 245 0.0034
971 DRUG EFFECT DECREASED 171 0.0032
972 LUNG NEOPLASM MALIGNANT 127 0.0031
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 219 0.0031
974 DRUG DOSE OMISSION 497 0.0030
975 INCORRECT DOSE ADMINISTERED 674 0.0029
976 NO ADVERSE EVENT 534 0.0029
977 PRODUCT QUALITY ISSUE 387 0.0028
978 INJECTION SITE PRURITUS 182 0.0027
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 550 0.0027
980 MULTIPLE SCLEROSIS RELAPSE 183 0.0027
981 INJECTION SITE REACTION 179 0.0026
982 MULTIPLE SCLEROSIS 120 0.0025
983 INJECTION SITE BRUISING 186 0.0023
984 ACCIDENTAL EXPOSURE TO PRODUCT 239 0.0023
985 INJECTION SITE ERYTHEMA 281 0.0023
986 INJECTION SITE PAIN 658 0.0021
987 INJECTION SITE SWELLING 164 0.0021
988 DEVICE ISSUE 190 0.0021
989 SUICIDE ATTEMPT 126 0.0021
990 DRUG ABUSE 162 0.0019
991 INJECTION SITE HAEMORRHAGE 127 0.0016
992 DRUG WITHDRAWAL SYNDROME 125 0.0014
993 DRUG DEPENDENCE 192 0.0012